These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 9813040

  • 1. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity.
    Richer JK, Lange CA, Manning NG, Owen G, Powell R, Horwitz KB.
    J Biol Chem; 1998 Nov 20; 273(47):31317-26. PubMed ID: 9813040
    [Abstract] [Full Text] [Related]

  • 2. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.
    Lange CA, Richer JK, Horwitz KB.
    Mol Endocrinol; 1999 Jun 20; 13(6):829-36. PubMed ID: 10379882
    [Abstract] [Full Text] [Related]

  • 3. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC, Gass-Handel EK, Wyszomierski SL, Doppler W, Leonhardt SA, Schaack J, Rosen JM, Watkin H, Anderson SM, Edwards DP.
    Mol Endocrinol; 2007 Jan 20; 21(1):106-25. PubMed ID: 16973758
    [Abstract] [Full Text] [Related]

  • 4. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
    Chughtai N, Schimchowitsch S, Lebrun JJ, Ali S.
    J Biol Chem; 2002 Aug 23; 277(34):31107-14. PubMed ID: 12060651
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. EGFR dependent expression of STAT3 (but not STAT1) in breast cancer.
    Berclaz G, Altermatt HJ, Rohrbach V, Siragusa A, Dreher E, Smith PD.
    Int J Oncol; 2001 Dec 23; 19(6):1155-60. PubMed ID: 11713584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response.
    Korpelainen EI, Kärkkäinen M, Gunji Y, Vikkula M, Alitalo K.
    Oncogene; 1999 Jan 07; 18(1):1-8. PubMed ID: 9926914
    [Abstract] [Full Text] [Related]

  • 10. CPAP is a novel stat5-interacting cofactor that augments stat5-mediated transcriptional activity.
    Peng B, Sutherland KD, Sum EY, Olayioye M, Wittlin S, Tang TK, Lindeman GJ, Visvader JE.
    Mol Endocrinol; 2002 Sep 07; 16(9):2019-33. PubMed ID: 12198240
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia activates signal transducers and activators of transcription 5 (STAT5) and increases its binding activity to the GAS element in mammary epithelial cells.
    Joung YH, Park JH, Park T, Lee CS, Kim OH, Ye SK, Yang UM, Lee KJ, Yang YM.
    Exp Mol Med; 2003 Oct 31; 35(5):350-7. PubMed ID: 14646587
    [Abstract] [Full Text] [Related]

  • 12. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
    Aoki N, Matsuda T.
    J Biol Chem; 2000 Dec 15; 275(50):39718-26. PubMed ID: 10993888
    [Abstract] [Full Text] [Related]

  • 13. Differentiation-dependent prolactin responsiveness and stat (signal transducers and activators of transcription) signaling in rat ovarian cells.
    Russell DL, Richards JS.
    Mol Endocrinol; 1999 Dec 15; 13(12):2049-64. PubMed ID: 10598581
    [Abstract] [Full Text] [Related]

  • 14. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5.
    Gewinner C, Hart G, Zachara N, Cole R, Beisenherz-Huss C, Groner B.
    J Biol Chem; 2004 Jan 30; 279(5):3563-72. PubMed ID: 14597631
    [Abstract] [Full Text] [Related]

  • 15. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
    Carsol JL, Gingras S, Simard J.
    Mol Endocrinol; 2002 Jul 30; 16(7):1696-710. PubMed ID: 12089361
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
    Rebsamen MC, Arrighi JF, Juge-Aubry CE, Vallotton MB, Lang U.
    J Mol Cell Cardiol; 2000 Apr 30; 32(4):599-610. PubMed ID: 10756117
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
    Luo G, Yu-Lee L.
    J Biol Chem; 1997 Oct 24; 272(43):26841-9. PubMed ID: 9341115
    [Abstract] [Full Text] [Related]

  • 18. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
    Quentmeier H, Zaborski M, Drexler HG.
    Leukemia; 1998 Oct 24; 12(10):1603-11. PubMed ID: 9766506
    [Abstract] [Full Text] [Related]

  • 19. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL.
    J Histochem Cytochem; 2002 Mar 24; 50(3):365-83. PubMed ID: 11850439
    [Abstract] [Full Text] [Related]

  • 20. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
    Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L.
    Dev Biol; 2001 Jan 01; 229(1):163-75. PubMed ID: 11133161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.